Status:
COMPLETED
Radiation Treatment of Lymph Node Recurrence From Prostate Cancer : is 11C-choline PET/CT Predictive of Survival Outcomes?
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
The role of PET/CT with Choline in the restaging of prostatic disease is now universally recognized, and its use has become routine in numerous centers in Italy and abroad. The indication for the test...
Eligibility Criteria
Inclusion
- patients operated with radical prostatectomy
- patients that present biochemical recurrence of the disease;
Exclusion
- patients \<18 years
Key Trial Info
Start Date :
October 8 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 25 2015
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT06170164
Start Date
October 8 2015
End Date
November 25 2015
Last Update
December 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Irccs San Raffaele
Milan, Italia, Italy